/RVP
RVP Stock - Retractable Technologies, Inc.
Healthcare|Medical - Instruments & SuppliesAMEX
$0.82-0.15%
$0.00 (-0.15%) • Dec 19
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.52
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.74
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.90
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RVP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.81 – $0.83
TARGET (TP)$0.95
STOP LOSS$0.76
RISK/REWARD1:2.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.14
52W High$1.14
52W Low$0.61
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $33.05M | $43.60M | $94.82M | $188.38M | $81.86M |
| Gross Profit | $-1,028,176 | $9.11M | $28.25M | $95.35M | $37.01M |
| Gross Margin | -3.1% | 20.9% | 29.8% | 50.6% | 45.2% |
| Operating Income | $-21,105,567 | $-11,488,209 | $-852,976 | $72.60M | $24.07M |
| Net Income | $-11,886,524 | $-7,011,036 | $5.08M | $56.06M | $24.22M |
| Net Margin | -36.0% | -16.1% | 5.4% | 29.8% | 29.6% |
| EPS | $-0.40 | $-0.24 | $0.15 | $1.65 | $0.80 |
Company Overview
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RVPBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.01
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $0.01 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.12 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.11 | — | — |
Q1 2025 | Mar 28, 2025 | — | $0.13 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.07 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.48 | — | — |
Q2 2024 | May 15, 2024 | — | $0.01 | — | — |
Q1 2024 | Mar 29, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.14 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.13 | — | — |
Q2 2023 | May 15, 2023 | — | $0.03 | — | — |
Q1 2023 | Mar 30, 2023 | — | $-0.13 | — | — |
Q4 2022 | Nov 14, 2022 | — | $0.16 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.02 | — | — |
Q2 2022 | May 17, 2022 | — | $0.22 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.61 | — | — |
Q4 2021 | Nov 15, 2021 | — | $0.19 | — | — |
Q3 2021 | Aug 17, 2021 | — | $0.31 | — | — |
Q2 2021 | May 17, 2021 | — | $0.52 | — | — |
Latest News
Retractable Technologies Says Tariffs Are Expected To Continue To Materially Impact Our Costs In Future Periods; Working To Lessen Financial Impact Of Tariffs & Have Shifted To A Larger Proportion Production To Us Facility
📉 NegativeBenzinga•Nov 14, 2025, 08:23 PM
Retractable Technologies Q3 EPS $0.01 Up From $(0.07) YoY, Sales $10.086M Down From $10.347M YoY
📈 PositiveBenzinga•Nov 14, 2025, 08:15 PM
Retractable Technologies' EasyPoint Blood Collection Tube Holder Earns Vizient Innovative Technology Designation
📈 PositiveBenzinga•Nov 14, 2025, 07:51 PM
Frequently Asked Questions about RVP
What is RVP's current stock price?
Retractable Technologies, Inc. (RVP) is currently trading at $0.82 per share. The stock has moved -0.15% today.
What is the analyst price target for RVP?
No analyst price targets are currently available for this stock.
What sector is Retractable Technologies, Inc. in?
Retractable Technologies, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the AMEX exchange.
What is RVP's market cap?
Retractable Technologies, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does RVP pay dividends?
No, Retractable Technologies, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCLGN
CollPlant Biotechnologies Ltd.
$1.52
Mkt Cap: $0.0B
FEMY
Femasys Inc.
$0.86
Mkt Cap: $0.0B
HBIO
Harvard Bioscience, Inc.
$0.75
Mkt Cap: $0.0B
NRSN
NeuroSense Therapeutics Ltd.
$0.81
Mkt Cap: $0.0B
NRXS
NeurAxis, Inc.
$3.22
Mkt Cap: $0.0B
NXGL
NEXGEL, Inc.
$1.62
Mkt Cap: $0.0B
NXL
Nexalin Technology, Inc.
$0.83
Mkt Cap: $0.0B
SCYX
SCYNEXIS, Inc.
$0.63
Mkt Cap: $0.0B
XCUR
Exicure, Inc.
$5.92
Mkt Cap: $0.0B
Explore stocks similar to RVP for comparison